Growth Metrics

Solesence (SLSN) EPS (Weighted Average and Diluted) (2017 - 2025)

Historic EPS (Weighted Average and Diluted) for Solesence (SLSN) over the last 9 years, with Q3 2025 value amounting to -$0.02.

  • Solesence's EPS (Weighted Average and Diluted) fell 15000.0% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year decrease of 6666.67%. This contributed to the annual value of $0.07 for FY2024, which is 17777.78% up from last year.
  • Solesence's EPS (Weighted Average and Diluted) amounted to -$0.02 in Q3 2025, which was down 15000.0% from $0.04 recorded in Q2 2025.
  • Over the past 5 years, Solesence's EPS (Weighted Average and Diluted) peaked at $0.04 during Q3 2024, and registered a low of -$0.04 during Q4 2022.
  • For the 5-year period, Solesence's EPS (Weighted Average and Diluted) averaged around -$0.0, with its median value being -$0.01 (2021).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 30000.0% in 2022, then surged by 30000.0% in 2025.
  • Solesence's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.01 in 2021, then tumbled by 300.0% to -$0.04 in 2022, then increased by 0.0% to -$0.04 in 2023, then soared by 75.0% to -$0.01 in 2024, then tumbled by 100.0% to -$0.02 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.02 for Q3 2025, versus $0.04 for Q2 2025 and -$0.01 for Q4 2024.